ChromoGenics announces recalculated terms for previous issued stock options (TO2) (translation of Swedish PM from February 21)
As a result of the recent rights issue the terms for the stock options (TO2) issued 2018 with strike 10-31 January 2020 will be recalculated. After recalculation every stock option of series TO2 will warrant a right to buy 1,62 shares to a price of 2,17 SEK. Maximally 30.655.062 new shares will be issued from the stock options which corresponds to a dilution by 17,7 percent. Bu full utilization of the options an additional capital of 66,4 MSEK will be brought to the company will